Chison Medical Technologies Co., Ltd. (SHA:688358)
China
· Delayed Price · Currency is CNY 29.55
+0.77 (2.68%)
May 6, 2025, 2:45 PM CST
SHA:688358 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | May '25 May 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2019 |
| Market Capitalization | 3,310 | 2,738 | 4,236 | 3,857 | 3,646 | 4,047 | Upgrade
|
| Market Cap Growth | -6.53% | -35.36% | 9.83% | 5.78% | -9.90% | -1.40% | Upgrade
|
| Enterprise Value | 2,194 | 1,674 | 3,253 | 2,837 | 2,679 | 3,059 | Upgrade
|
| Last Close Price | 29.52 | 24.42 | 36.57 | 32.79 | 30.60 | 33.46 | Upgrade
|
| PE Ratio | 24.18 | 19.49 | 28.92 | 36.44 | 32.42 | 40.62 | Upgrade
|
| PS Ratio | 7.26 | 5.84 | 8.76 | 10.13 | 9.17 | 12.15 | Upgrade
|
| PB Ratio | 2.26 | 1.93 | 3.09 | 2.94 | 2.93 | 3.39 | Upgrade
|
| P/TBV Ratio | 2.30 | 1.96 | 3.14 | 2.99 | 2.98 | 3.46 | Upgrade
|
| P/FCF Ratio | 26.11 | 20.77 | 81.62 | 334.47 | 4701.59 | 78.49 | Upgrade
|
| P/OCF Ratio | 24.45 | 19.46 | 49.31 | 60.51 | 91.25 | 49.09 | Upgrade
|
| EV/Sales Ratio | 4.81 | 3.57 | 6.72 | 7.45 | 6.74 | 9.18 | Upgrade
|
| EV/EBITDA Ratio | 17.88 | 13.53 | 25.99 | 36.23 | 32.86 | 33.84 | Upgrade
|
| EV/EBIT Ratio | 20.12 | 14.95 | 28.53 | 42.84 | 37.09 | 37.21 | Upgrade
|
| EV/FCF Ratio | 17.30 | 12.70 | 62.68 | 245.99 | 3454.78 | 59.32 | Upgrade
|
| Debt / Equity Ratio | 0.00 | 0.01 | 0.01 | 0.01 | 0.00 | - | Upgrade
|
| Debt / EBITDA Ratio | 0.05 | 0.05 | 0.08 | 0.08 | 0.02 | - | Upgrade
|
| Debt / FCF Ratio | 0.05 | 0.05 | 0.20 | 0.53 | 1.76 | - | Upgrade
|
| Asset Turnover | 0.29 | 0.30 | 0.32 | 0.26 | 0.29 | 0.25 | Upgrade
|
| Inventory Turnover | 1.72 | 1.47 | 1.25 | 1.08 | 1.95 | 1.96 | Upgrade
|
| Quick Ratio | 8.76 | 7.58 | 8.58 | 5.97 | 8.33 | 9.11 | Upgrade
|
| Current Ratio | 9.55 | 8.42 | 9.69 | 7.10 | 9.09 | 9.85 | Upgrade
|
| Return on Equity (ROE) | 9.49% | 10.07% | 10.92% | 8.27% | 9.22% | 8.43% | Upgrade
|
| Return on Assets (ROA) | 4.31% | 4.49% | 4.69% | 2.84% | 3.29% | 3.89% | Upgrade
|
| Return on Capital (ROIC) | 4.71% | 4.99% | 5.28% | 3.23% | 3.70% | 4.35% | Upgrade
|
| Return on Capital Employed (ROCE) | 7.40% | 7.80% | 8.20% | 5.00% | 5.70% | 6.70% | Upgrade
|
| Earnings Yield | 4.13% | 5.13% | 3.46% | 2.74% | 3.08% | 2.46% | Upgrade
|
| FCF Yield | 3.83% | 4.81% | 1.23% | 0.30% | 0.02% | 1.27% | Upgrade
|
| Dividend Yield | 2.78% | - | 2.19% | 2.14% | 1.17% | 1.71% | Upgrade
|
| Payout Ratio | 65.53% | 63.70% | 53.58% | 37.79% | 56.90% | 80.29% | Upgrade
|
| Buyback Yield / Dilution | -1.72% | -1.25% | 2.19% | -0.11% | -0.79% | -28.88% | Upgrade
|
| Total Shareholder Return | 1.06% | -1.25% | 4.37% | 2.02% | 0.37% | -27.18% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.